Ian Mortimer, PRESIDENT & CEO at Xenon Pharmaceuticals Inc. (XENE), sold 75,693 shares at $41.44 ($3.1M) on 2023-05-24, disclosed to the SEC on 2023-05-26.
Open-market sale of $3.1M XENE by PRESIDENT & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.37 | 13,179 | $545K | 17.4% |
| 2 | $41.37 | 13,179 | $545K | 17.4% |
| 3 | $41.44 | 17,069 | $707K | 22.5% |
| 4 | $41.44 | 17,069 | $707K | 22.5% |
| 5 | $41.49 | 1,407 | $58K | 1.9% |
| 6 | $41.49 | 1,407 |
| $58K |
| 1.9% |
| 7 | $41.84 | 7,310 | $306K | 9.7% |
| 8 | $41.84 | 3,902 | $163K | 5.2% |
| 9 | $41.84 | 1,171 | $49K | 1.6% |
| Total | $41.48 avg | 75,693 | $3.1M | 100% |
| Filing → |
| XENE | SELL | 2026-03-11 | $17.6M | — | Filing → |
| XENE | SELL | 2026-01-02 | $1.8M | — | Filing → |
| XENE | SELL | 2025-12-09 | $2.3M | — | Filing → |